Literature DB >> 8772541

Clinical review 78: Aromatase deficiency in women and men: would you have predicted the phenotypes?

S E Bulun1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8772541     DOI： 10.1210/jcem.81.3.8772541

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  Prepubertal girls with premature adrenarche have greater bone mineral content and density than controls.

Authors:  A B Sopher; J C Thornton; M E Silfen; A Manibo; S E Oberfield; J Wang; R N Pierson; L S Levine; M Horlick
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

Review 2.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

3.  An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors.

Authors:  Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2013-12       Impact factor: 5.958

4.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta.

Authors:  J H Krege; J B Hodgin; J F Couse; E Enmark; M Warner; J F Mahler; M Sar; K S Korach; J A Gustafsson; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 5.  Defects of steroidogenesis.

Authors:  A Biason-Lauber; M Boscaro; F Mantero; G Balercia
Journal:  J Endocrinol Invest       Date:  2010-02-24       Impact factor: 4.256

Review 6.  Reflections on the diseases linked to mutations of the androgen receptor.

Authors:  Angelo Poletti; Paola Negri-Cesi; Luciano Martini
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.925

7.  GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice.

Authors:  Jeffery Ford; Asghar Hajibeigi; Michael Long; Lisa Hahner; Crystal Gore; Jer-Tseng Hsieh; Deborah Clegg; Joseph Zerwekh; Orhan K Oz
Journal:  J Bone Miner Res       Date:  2011-02       Impact factor: 6.741

8.  Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.

Authors:  Jan Idkowiak; Stephen O'Riordan; Nicole Reisch; Ewa M Malunowicz; Felicity Collins; Michiel N Kerstens; Birgit Köhler; Luitgard Margarete Graul-Neumann; Maria Szarras-Czapnik; Mehul Dattani; Martin Silink; Cedric H L Shackleton; Dominique Maiter; Nils Krone; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2010-12-29       Impact factor: 5.958

9.  Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency.

Authors:  Yena Lee; Jin-Ho Choi; Arum Oh; Gu-Hwan Kim; Sook-Hyun Park; Jung Eun Moon; Cheol Woo Ko; Chong-Kun Cheon; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-06-30

10.  Novel CYP19A1 Mutations Extend the Genotype-Phenotype Correlation and Reveal the Impact on Ovarian Function.

Authors:  Valiyaparambil Pavithran Praveen; Asmahane Ladjouze; Kay-Sara Sauter; Annie Pulickal; Efstathios Katharopoulos; Mafalda Trippel; Aurel Perren; Amit V Pandey; Christa E Flück
Journal:  J Endocr Soc       Date:  2020-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.